"Florida Cancer Specialists provides the most advanced cancer treatment options available, close to home, and personalized for each patient’s unique needs. At our Tallahassee Cancer Center, we provide treatment for all forms of cancers and blood disorders, including laboratory, pharmacy, gynecologic oncology, nutritional counseling and care management. Clinical trials and Dignicap® available."

During the past decade, Florida Cancer Specialists Panhandle conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 2 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 2 clinical trials were completed. i.e. 11.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Florida Cancer Specialists Panhandle" #1 sponsor was "Novartis Pharmaceuticals" with 5 trials, followed by "ImmunoGen, Inc." with 3 trials sponsored, "Arcus Biosciences, Inc." with 2 trials sponsored, "Daiichi Sankyo, Inc." with 2 trials sponsored and "Loxo Oncology, Inc." with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Cancer Specialists Panhandle" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "BeiGene" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Florida Cancer Specialists Panhandle" are "Fallopian Tube Cancer" (3 trials), "Non-Small Cell Lung Cancer" (3 trials), "Peritoneal Cancer" (3 trials), "Epithelial Ovarian Cancer" (2 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "Florida Cancer Specialists Panhandle" in a lesser frequency.

Most popular intervention types in "Florida Cancer Specialists Panhandle" are "Drug" (29 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (2 trials), "Elotuzumab" (2 trials), "Etrumadenant" (2 trials), "Mirvetuximab Soravtansine" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Florida Cancer Specialists Panhandle" are 24 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Florida Cancer Specialists Panhandle". undefined are not yet recruiting, 8 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Florida Cancer Specialists Panhandle, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Florida Cancer Specialists Panhandle, 3 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".